15 July 2024
Braveheart Investment Group plc
("Braveheart" or the "Company")
Grant of options
Braveheart Investment Group (AIM: BRH), announces that the Company has granted options today over a total of 3,100,000 ordinary shares of 2p each in the Company ("Ordinary Shares") to the Directors, one employee and one service provider to the Company (the "Options"). The Options have been granted pursuant to the Company's share option plan adopted on 16 December 2020.
In aggregate, 2,800,000 Options have been granted to Directors of the Company, as follows:
| Name | No. options over Ordinary Shares previously held | No. Options granted | Exercise price | Resultant holding of options over Ordinary Shares held | Percentage of the current issued share capital of the Company |
| Trevor Brown | 2,750,000 | 1,500,000 | 1,000,000: 4.5p 500,000: 6.5p | 4,250,000 | 6.67% |
| Vivian Hallam | 3,226,192 | 1,000,000 | 666,667: 4.5p 333,333: 6.5p | 4,226,192 | 6.63% |
| Susan Hagan | 250,000 | 150,000 | 4.5p | 400,000 | 0.63% |
| Qu Li | 200,000 | 150,000 | 4.5p | 350,000 | 0.55% |
The Options granted to Vivian Hallam, Trevor Brown, Susan Hagan and Qu Li are unapproved options.
The 300,000 Options granted to the employee and service provider have an exercise price of 4.5p.
The Options granted to the Directors shall vest over a three-year period in equal tranches, with one third vesting on the first anniversary of the date of the grant, one third vesting on the second anniversary of the date of the grant and one third on the third anniversary of the date of the grant, subject to continued employment.
The Options granted to Trevor Brown and Vivian Hallam, as Executive Directors of the Company, have an additional performance related vesting criteria that the closing mid-market price of an Ordinary Share must equal or exceed 7.75 pence for 15 business days out of a 30 consecutive business day period.
Following the grant of the Options, the Company now has options outstanding over a total of 10,122,192 Ordinary Shares, equivalent to 15.9% of the Company's current issued share capital.
Further details of the Options can be found in the Notification of Dealing Form below.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||||||||||
| a)
| Name
|
| ||||||||||||
| 2
| Reason for the notification
| |||||||||||||
| a)
| Position/status
| See 1a) above | ||||||||||||
| b)
| Initial notification /Amendment
| Initial Notification | ||||||||||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||||||||||
| a)
| Name
| Braveheart Investment Group plc | ||||||||||||
| b)
| LEI
| 2138006HQ3COMU626I61 | ||||||||||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||||||||||
| a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares of 2 pence each in Braveheart Investment Group plc
| ||||||||||||
| b)
| Nature of the transactions
| Grant of options over ordinary shares | ||||||||||||
| c)
| Price(s) and volume(s)
| Price: Exercise price of 4.5p per option
Price: Exercise price of 6.5p per option
| ||||||||||||
| d)
| Aggregated information - Aggregated volume - Price - Principal amount
| N/A
| ||||||||||||
| e)
| Dates of the transaction
| 15 July 2024 | ||||||||||||
| | | | ||||||||||||
| f) | Place of transaction | Outside a trading venue | ||||||||||||
For further information:
| | |
| Braveheart Investment Group plc | Tel: 01738 587555 |
| Trevor Brown CEO | |
| | |
| Allenby Capital Limited (Nominated Adviser and Joint Broker) | Tel: 020 3328 5656 |
| James Reeve / George Payne | |
| | |
| Peterhouse Capital Limited (Joint Broker) | Tel: 020 7469 0936 |
| Duncan Vasey / Lucy Williams | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.